Minaris Advanced Therapies Capabilities Update March 2026: Cell & Gene Therapy

Minaris Advanced Therapies is a specialized global CDMO focused exclusively on cell and gene therapies, leveraging over 25 years of experience to support clients across the US, Europe, and Asia. The organization balances scale with personalized service, positioning itself as a trusted partner for multiple commercial therapies worldwide. Its comprehensive offerings span the entire development lifecycle, including process and analytical development, GMP manufacturing, and integrated testing to ensure efficient and compliant lot release. By combining deep technical expertise with a global operational footprint, the CDMO enables clients to accelerate timelines from early development to commercial production. Its approach emphasizes reliability, quality, and adaptability, catering to the unique needs of advanced therapy developers. With a focus on both innovation and execution, the organization serves as a seamless extension of its clients’ teams, helping transform promising cell and gene therapy concepts into commercially viable treatments.